期刊文献+

HPLC同时测定复方倍他米松注射液中倍他米松磷酸钠和二丙酸倍他米松的含量 被引量:10

Simultaneous HPLC determination of betamethasone sodium phosphate and betamethasone dipropionate in compound betamethasone injection
下载PDF
导出
摘要 目的 测定复方倍他米松注射液中倍他米松磷酸钠和二丙酸倍他米松的含量。方法 采用高效液相色谱法 ,以甲醇 0 .0 5mol·L-1磷酸二氢钾溶液为流动相进行梯度洗脱 ,以氟米松为内标 ,检测波长为 2 5 4nm。结果 倍他米松磷酸钠和二丙酸倍他米松分别在浓度为 0 .0 37~ 0 .36 6mg·mL-1(r =1.0 0 0 0 ,n =6 )和 0 .0 87~ 0 .86 8mg·mL-1(r=0 .9996 ,n =6 )范围内呈良好线性关系。倍他米松磷酸钠和二丙酸倍他米松的平均加样回收率分别为 10 1.3%(RSD =1.3%,n =9)和 99.0 %(RSD =1.3%,n =9)。结论 方法简便、快速、准确 ,能同时测定复方倍他米松注射液中倍他米松磷酸钠和二丙酸倍他米松。 OBJECTIVE A reversed phase HPLC method was developed to determine the contents of betamethasone sodium phosphate and betamethasone dipopinate simultaneously in compound betamethasone injection.METHODS The analysis was carried on a column of Shim-Pack CLC-ODS (4.6 mm×150 mm) with a mobile phase of methanol-0.05 mol·L -1 potassium dihydrogen phosphate solution (gradient elution from 58∶42 to 75∶25 in 18 minutes),using fluoromethasone as the internal substance.The detection wavelength was at 254 nm.RESULTS The linear range was 0.03 664~0.3 664 mg·mL -1(r=1.000 0,n=6) for betamethasone sodium phosphate and 0.087~0.868 mg·mL -1 for betamethasone dipropionate (r=0.999 6,n=6).The average recoveries of betamethasone sodium phosphate and betamethasone dipropionate were 101.3% (RSD=1.3%,n=9) and 99.0% (RSD=1.3%,n=9),respectively.The reproducibilities of the method (RSD) were 0.31% and 0.14% (n=7),respectively.CONCLUSION This method is rapid,simple and accurate.
作者 金薇 汪洁
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2002年第1期48-50,共3页 Chinese Pharmaceutical Journal
关键词 高效液相色谱法 复方倍他米松注射液 倍他米松磷酸钠 二丙酸倍他米松 氟米松 HHPLC 含量 HPLC compound betamethasone injection betamethasone sodium phosphate betamethasone dipropionate fluoromethasone
  • 相关文献

参考文献1

  • 1马星航 秦芝玲.甾类孕激素的高效液相色谱分离流动相选择最优化法[J].药学学报,1987,22(6):448-448.

同被引文献20

  • 1陈丽莎,袁定芬.复方倍他米松与地塞米松治疗急性荨麻疹的对比观察[J].世界临床药物,2004,25(6):376-377. 被引量:1
  • 2吴慧,赵东,孙国华.舒其松联合恩丹西酮防治化疗药物致胃肠道反应疗效观察[J].中国煤炭工业医学杂志,2004,7(11):1096-1097. 被引量:2
  • 3吴慧,赵东,李春红.右倍他米松磷酸钠(舒其松)治疗创伤性脑水肿疗效观察[J].中国医院用药评价与分析,2005,5(3):171-173. 被引量:2
  • 4.中国药典.2000.二部[M].,.730.
  • 5WS-10001-(HD-1598)-2003,国家药品标准·右倍他米松磷酸钠注射液[S].
  • 6Wollstein R, Chaimsky G, Carlson L, et al. Evaluating short-term pain after steroid injection[J]. Am J Orthop,2007,36(3):128-131.
  • 7国家食品药品监督管理局药品审评中心,四川美康医药软件研究开发有限公司.药物临床信息参考[M].四川:四川科学技术出版社,2004:681.
  • 8Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model[J]. Int J Oral Maxillofac Surg,2009,38(4):350-355.
  • 9右倍他米松磷酸钠注射液国家药品标准[S].WS-10001-(HD-1598)-2003.
  • 10Xiong Y, Xiao KP, Rustum AM. Development and validation of a stability-indicating RP-HPLC method to separate low levels of dexamethasone and other related compounds from betamethasone[J]. J Pharm Biomed Anal,2009,49(3):646-654.

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部